Latest Articles

Publication Date
Identification and validation of lactate-related gene signatures in endometriosis for clinical evaluation and immune characterization by WGCNA and machine learning.

Endometriosis is a common benign gynecologic disease in women of reproductive age, and its manifestations remarkably decrease quality of life. Lactate, as a metabolite, exerts prominent effects across a wide …

Published: Oct. 7, 2025, midnight
Impact of endocrine disruptors on female fertility: an update.

Endocrine disruptors (EDs) are a heterogeneous group of natural or synthetic chemicals capable of interfering with hormonal regulation. Widely present in plastics, cosmetics, pesticides, food packaging, and household products, they …

Published: Oct. 7, 2025, midnight
Early-onset uterine cancer research seeks new therapy development for younger patients - Today@Wayne

Early-onset uterine cancer research seeks new therapy development for younger patients Today@Wayne

Published: Oct. 6, 2025, 4:10 p.m.
International honours for Auckland University women’s health researcher - Inside Government NZ

International honours for Auckland University women’s health researcher Inside Government NZ

Published: Oct. 5, 2025, 11:17 p.m.
Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 - BioSpace

Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 BioSpace

Published: Oct. 3, 2025, 10:53 a.m.
Eisai Highlights Breadth of Oncology Research at ESMO 2025 - JCN Newswire

Eisai Highlights Breadth of Oncology Research at ESMO 2025 JCN Newswire

Published: Oct. 3, 2025, 9:01 a.m.
Eisai Highlights Breadth of Oncology Research at ESMO 2025 - ACN Newswire - ACN Newswire

Eisai Highlights Breadth of Oncology Research at ESMO 2025 - ACN Newswire ACN Newswire

Published: Oct. 3, 2025, 9:01 a.m.
Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 - Morningstar

Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 Morningstar

Published: Oct. 2, 2025, 12:08 p.m.
The dual nature of immunotherapy in female reproductive disorders: immune homeostasis and clinical challenges.

The female reproductive system (FRS) exhibits unique immunological characteristics, balancing defense against pathogens with tolerance to sperm and semi-allogeneic embryos. Key players include decidual natural killer (dNK) cells, immune checkpoint …

Published: Oct. 2, 2025, midnight
Circulating microRNAs and Endometriosis: A Comprehensive Analysis and Validation of Identified Biomarkers in the Indian Population.

Endometriosis is a prevalent condition where tissue similar to the uterine lining grows outside the uterus, causing pain and infertility. Diagnosing endometriosis typically requires invasive procedures like laparoscopy. MicroRNAs (miRNAs) …

Published: Oct. 1, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!